These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30481294)

  • 41. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
    Müller HW
    Glia; 2000 Jan; 29(2):182-5. PubMed ID: 10625337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
    Kagiava A; Sargiannidou I; Theophilidis G; Karaiskos C; Richter J; Bashiardes S; Schiza N; Nearchou M; Christodoulou C; Scherer SS; Kleopa KA
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2421-9. PubMed ID: 27035961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable Electroceutical Approach Improves Myelination by Restoring Membrane Integrity in a Mouse Model of Peripheral Demyelinating Neuropathy.
    Intisar A; Shin HY; Kim WH; Kang HG; Kim MY; Kim YS; Cho Y; Mo YJ; Lim H; Lee S; Lu QR; Lee YI; Kim MS
    Adv Sci (Weinh); 2022 Nov; 9(32):e2201358. PubMed ID: 35975427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partial loss-of-function variant in neuregulin 1 identified in family with heritable peripheral neuropathy.
    Lysko DE; Meireles AM; Folland C; McNamara E; Laing NG; Lamont PJ; Ravenscroft G; Talbot WS
    Hum Mutat; 2022 Sep; 43(9):1216-1223. PubMed ID: 35485770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).
    Prukop T; Stenzel J; Wernick S; Kungl T; Mroczek M; Adam J; Ewers D; Nabirotchkin S; Nave KA; Hajj R; Cohen D; Sereda MW
    PLoS One; 2019; 14(1):e0209752. PubMed ID: 30650121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An In Vitro Model of Charcot-Marie-Tooth Disease Type 4B2 Provides Insight Into the Roles of MTMR13 and MTMR2 in Schwann Cell Myelination.
    Robinson DC; Mammel AE; Logan AM; Larson AA; Schmidt EJ; Condon AF; Robinson FL
    ASN Neuro; 2018; 10():1759091418803282. PubMed ID: 30419760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of immune cells in animal models for inherited peripheral neuropathies.
    Wang Ip C; Kroner A; Fischer S; Berghoff M; Kobsar I; Mäurer M; Martini R
    Neuromolecular Med; 2006; 8(1-2):175-90. PubMed ID: 16775375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
    Houlden H; Reilly MM
    Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Axonal neuregulin-1 regulates myelin sheath thickness.
    Michailov GV; Sereda MW; Brinkmann BG; Fischer TM; Haug B; Birchmeier C; Role L; Lai C; Schwab MH; Nave KA
    Science; 2004 Apr; 304(5671):700-3. PubMed ID: 15044753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.
    Fledrich R; Stassart RM; Klink A; Rasch LM; Prukop T; Haag L; Czesnik D; Kungl T; Abdelaal TA; Keric N; Stadelmann C; Brück W; Nave KA; Sereda MW
    Nat Med; 2014 Sep; 20(9):1055-61. PubMed ID: 25150498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A dual role of erbB2 in myelination and in expansion of the schwann cell precursor pool.
    Garratt AN; Voiculescu O; Topilko P; Charnay P; Birchmeier C
    J Cell Biol; 2000 Mar; 148(5):1035-46. PubMed ID: 10704452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy.
    Hong YB; Joo J; Hyun YS; Kwak G; Choi YR; Yeo HK; Jwa DH; Kim EJ; Mo WM; Nam SH; Kim SM; Yoo JH; Koo H; Park HT; Chung KW; Choi BO
    PLoS Genet; 2016 Feb; 12(2):e1005829. PubMed ID: 26828946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G; Visigalli D; Prukop T; Cervellini I; Mannino E; Venturi C; Bruzzone S; Sereda MW; Schenone A
    Neurobiol Dis; 2016 Nov; 95():145-57. PubMed ID: 27431093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
    Chumakov I; Milet A; Cholet N; Primas G; Boucard A; Pereira Y; Graudens E; Mandel J; Laffaire J; Foucquier J; Glibert F; Bertrand V; Nave KA; Sereda MW; Vial E; Guedj M; Hajj R; Nabirotchkin S; Cohen D
    Orphanet J Rare Dis; 2014 Dec; 9():201. PubMed ID: 25491744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression.
    Decker L; Desmarquet-Trin-Dinh C; Taillebourg E; Ghislain J; Vallat JM; Charnay P
    J Neurosci; 2006 Sep; 26(38):9771-9. PubMed ID: 16988048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons.
    Maier M; Castagner F; Berger P; Suter U
    Mol Cell Neurosci; 2003 Nov; 24(3):803-17. PubMed ID: 14664827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severity of Demyelinating and Axonal Neuropathy Mouse Models Is Modified by Genes Affecting Structure and Function of Peripheral Nodes.
    Morelli KH; Seburn KL; Schroeder DG; Spaulding EL; Dionne LA; Cox GA; Burgess RW
    Cell Rep; 2017 Mar; 18(13):3178-3191. PubMed ID: 28355569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.